Delivery Order SPE2DB22D2211-SPE2DB25FRZEL
Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,597.88 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringes. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,613.80 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 4, 2025, and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the location of performance for this delivery order, which falls under the company's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,523.83 to AmerisourceBergen Drug Corp for the supply of 1,440 units of Havrix vaccine (1 ml syringes) with a completion date of June 30, 2025. This firm fixed-price contract, awarded on June 27, 2025, with no set-aside designation, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive award to a critical pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of HAVRIX 1,440 Unit/ML Syringe vaccines valued at $1,339.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for completion by August 7, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency has awarded a delivery order valued at $20,231.75 to AmerisourceBergen Drug Corp for the supply of 1,440 units/mL of HAVRIX vaccine in syringe form. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, awarded on August 4, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,048.80 delivery order to AmerisourceBergen Drug Corp for Havrix 720 Unit/0.5 ML syringes on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The vaccine product will be...
- The Defense Logistics Agency (DLA) awarded a $1,417.08 delivery order to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes, with an ultimate completion date of July 14, 2025. This firm fixed-price contract, awarded on July 11, 2025, is non-set-aside and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order valued at $3,720.77 to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine in syringe form. This non-competitive, firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The vaccine will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for 1,440 units/mL of Havrix vaccine in syringe form, with a ceiling value of $1,234.12. This is a firm fixed-price delivery order with no set-aside designation, executed competitively, and scheduled for completion by September 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...